Skip to main content
Clinical Trials/CTRI/2020/12/029501
CTRI/2020/12/029501
Completed
Phase 4

COMPARATIVE EVALUATION OF ANALGESIC EFFICACY OF 0.125% ROPIVACAINE WITH FENTANYL AND 0.2% ROPIVACAINE ALONE IN COMBINED SPINAL EPIDURAL ANAESTHESIA

Department of Anaesthesiology0 sites60 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Department of Anaesthesiology
Enrollment
60
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 30, 2021
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Anaesthesiology

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients of either gender aged between 18 to 65 years.
  • 2\) ASA grade 1 and 2
  • 3\) patients scheduled for elective lower limb orthopaedic surgeries under combined spinal epidural anaesthesia.

Exclusion Criteria

  • 1\) All patients with ASA grade 3 and above,
  • 2\) ALL patients with known allergy to study drugs.
  • 3\) All known contraindications to spinal anaesthesia and epidural insertions
  • 4\) Patients with previous spine abnormalities and spine surgeries.
  • 5\)Patients with history of underlying neuromuscular and pyschological disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials